What are you searching for?

05.09.2022 | Tracker

Top 50 Pharma Tracker

By Francesca Gan and Chawanzi Chintu

Top 50 Pharma Tracker: HCPs track Pharma Covid-19 developments online

Discover what healthcare professionals (HCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are HCPs responding to drug launch news? How are HCPs talking about or engaging with the Top 50 pharma companies on social media? Each week, CREATION.co’s tracking updates bring you the latest insights from the conversation of HCPs across the globe discussing these topics and more.

The Top 50 Pharmaceutical Companies mentioned by HCPs on Twitter

August RankJuly RankCompany
Name
Total
Mentions
Account
Mentions
Account
Retweets
11Pfizer4,85141823
22Moderna3,077620
33Johnson & Johnson71520640
44AstraZeneca70535422
514Eli Lilly4271025
65GSK38913527
78Novartis37218739
86Abbott3192872
99Bayer2997812
107Roche2868718
1113Merck & Co2361325
1218Gilead Sciences2287920
1312Sanofi2009212
1410Novo Nordisk17813410
1524Amgen997110
1619AbbVie96587
1731Daiichi Sankyo79422
1817BMS75550
1921Boehringer Ingelheim746029
2023Stada6700
2122Takeda56415
2226Servier52436
2325Regeneron51281
2416Biogen36200
2532Organon3400
2611Otsuka3330
2715Fresenius32215
2827Teva31219
2933CSL29258
3020Eisai2640
3135Ipsen2191
3228Bausch1410
3334Merck KGaA13112
3430Astellas1240
3541Sun1281
3637UCB960
3739Jazz Pharmaceuticals800
3829Vertex870
3942Alexion710
4038Grifols500
4140Menarini422
4250CSPC300
4336Viatris310
4443Kyowa Kirin100
4450Aurobindo100
5050Jiangsu Hengrui000
5050Endo000
5050Sino000
5050Shanghai000
5050Sumitomo Dainippon000

The latest insights from HCPs mentioning the Top 50 Pharmaceutical Companies

The five pharmaceutical companies that were mentioned the most by HCPs on Twitter during August 2022 were Pfizer, Moderna, Johnson & Johnson, AstraZeneca and Eli Lilly.

Graph sowing t he most mentioned pharmaceutical companies on Twitter by HCPs in August

 

The number of mentions of pharmaceutical companies identified by CREATION.co in August 2022 remained largely unchanged from the previous month with the only notable difference being the rise in online mentions of Eli Lilly, causing it to climb into the top 5 most mentioned pharmaceutical companies by HCPs online.

Moderna remained the second most mentioned pharmaceutical company with HCPs sharing tweets about Moderna’s campaign to claim sole rights to the mRNA COVID-19 vaccine technology.

 

The top shared links by HCPs discussed:

  1. A Press Announcement from the FDA announcing the authorisation of Moderna, Pfizer-BioNTech Bivalent COVID-19 Vaccines for use as a booster dose.
  2. A Twitter event post about the US FDA’s authorisation of Pfizer and Moderna’s updated COVID-19 boosters targeting Omicron subvariants.
  3. A News Article from the BBC about COVID-19 vaccine technology.

A Bar chart showing drivers of conversation in August 2022

One of the key drivers of conversation in August 2022 came from HCP discussions about the approval of Moderna’s bivalent COVID-19 vaccine in the United Kingdom. HCPs retweeted the announcement of the approval made by @MHRAgovuk – Medicines & Healthcare products regulatory agency.

HCPs including Dr Megan Ranney shared positive views about the approval of the vaccine, calling the approval ‘big news’. Additionally, Dr Megan Ranney, shared a Twitter thread about “What do I do this fall”. The thread encouraged her followers to think about the need for vaccine updates and boosters to improve efficacy against existing and future variants.

Eli Lilly made its way into the top 5 most mentioned pharmaceutical companies by HCPs in August 2022. HCPs mentioned Eli Lilly when discussing advances in their obesity treatment tirzepatide. HCPs were excited and positive about advances in treatment sharing that forthcoming indications are moving full steam ahead with great momentum and a bright future, also, stating that obesity treatment is entering an exciting new era.

 

CREATION.co continues to analyse online HCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.

To stay up to date, you can sign up to CREATION.co’s monthly eJournal.

Methodology notes:

  • In August 2022, CREATION Pinpoint® identified 11,240 healthcare professional (HCP) authored tweets from 5,201 individual HCPs mentioning a Top 50 Pharmaceutical company (according to revenue). 
  • Data for this research was analysed from the online Twitter conversations of HCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 August and 31 August 2022.
  • Unless otherwise specified, mentions of a company are not limited to its Twitter account(s).
  • In some cases, a tweet may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
  • Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Janssen. In August 58 of these posts mentioned Janssen.

The Top 50 Pharma tracker archive

July 2022:

Top 50 Pharma Tracker: HCPs continue to discuss Moderna’s COVID-19 vaccine but mentions of Pfizer dramatically decrease

Top 50 Table
Top 50 Insights

June 2022: Top 50 Pharma Tracker: HCPs share mixed opinions on COVID-19 vaccines and treatment data

Top 50 Table
Top 50 Insights

May 2022: Top 50 Pharma Tracker: HCPs discuss Pfizer vaccine documents and share opinions on COVID-19 vaccine efficacy.

Top 50 Table
Top 50 Insights

April 2022: HCPs celebrate the success of Lilly’s tirzepatide for obesity and discuss COVID-19 vaccine efficacy

Top 50 Table
Top 50 Insights

March 2022: HCPs compare immune responses of T cell, B cell, and Antibodies to different COVID-19 vaccines.

Top 50 Table
Top 50 Insights

February 2022: HCPs discuss Healthcare inequity and vaccination of under 5 year olds

Top 50 Table
Top 50 Insights

January 2022: HCPs get political when discussing Regeneron’s COVID-19 treatment

Top 50 Table
Top 50 Insights

December 2021: Omicron variant dominates HCP conversation in December 2021

Top 50 Table
Top 50 Insights

November 2021 : HCPs discuss trial data of Pfizer’s COVID-19 booster vaccine and oral treatment

Top 50 Table
Top 50 Insights

October 2021 : Pfizer most discussed company with booster and children’s COVID-19 jabs

Top 50 Table
Top 50 Insights

July 2021: HCPs discuss “booster shot” to decrease the high spread of the Delta variant

Top 50 Table
Top 50 Insights

June 2021: HCPs discuss effectiveness of COVID-19 vaccines against delta strain.

Top 50 Table
Top 50 Insights

May 2021: HCPs discuss accessibility of COVID-19 treatments globally.

Top 50 Table
Top 50 Insights

April 2021: HCPs reassure the public as they discuss COVID-19 vaccine side effects.

Top 50 Table
Top 50 Insights

March 2021: Oxford-AstraZeneca vaccine provokes HCP conversation as they discuss blood clots as a side effect.

Top 50 Table
Top 50 Insights

February 2021: J&J FDA approval of single-dose vaccine stirs HCP conversations

Top 50 Table
Top 50 Insights

January 2021: J&J new vaccine data drives increase in company posts online

Top 50 Table
Top 50 Insights

December 2020: COVID-19 makes up 84% of total conversation

Top 50 Table
Top 50 Insights

November 2020: Vaccine success dwarfs all other conversation.

Top 50 Table
Top 50 Insights

October 2020: Regeneron tops list due to high profile COVID-19 treatment conversation.

Top 50 Table
Top 50 Insights

September 2020: ASTRAZENECA’S VACCINE TRIAL SAFETY DISCUSSED BUT TRANSPARENCY IS CELEBRATED.

Top 50 Table
Top 50 Insights

August 2020: HCPS DISCUSS ASTRAZENECA MORE THAN GILEAD FOR FIRST TIME SINCE PANDEMIC

Top 50 Table
Top 50 Insights

July 2020: COVID-19 CANDIDATES TAKE OVER ALL HCP CONVERSATION

Top 50 Table
Top 50 Insights

June 2020: HCPs respond to COVID-19 treatment options

Top 50 Table
Top 50 Insights

May 2020: HCPs track pharma covid-19 developments online

Top 50 Table
Top 50 Insights

April 2020: HCPS RESPOND TO PHARMA COVID-19 ACTIVITY

Top 50 Table
Top 50 Insights

March 2020: HCPS MENTIONING PHARMA IN RELATION TO COVID-19

Top 50 Table
Top 50 Insights

February 2020: HCPS DISCUSS GILEAD, EISAI AND MERCK & CO’S TRIAL RESULTS

Top 50 Table
Top 50 Insights

January 2020: NEW YEAR BEGINS WITH FAILED TRIALS AND SUCCESSFUL PODCAST LAUNCH

Top 50 Table
Top 50 Insights

December 2019: @NOVARTIS MOST MENTIONED TWITTER ACCOUNT FOR SECOND MONTH

Top 50 Table
Top 50 Insights

November 2019: GILEAD INTO TOP 5 AFTER PRICE DISCREPANCY

Top 50 Table
Top 50 Insights

October 2019: HCPS ENGAGE WITH TOP 50 PHARMA AROUND GOOD AND BAD NEWS

Top 50 Table
Top 50 Insights

September 2019: HCPS ENGAGED MEANINGFULLY WITH TOP 50 PHARMA

Top 50 Table
Top 50 Insights

August 2019: #WHATHCPSTHINK ABOUT THE TOP 50 PHARMA

Top 50 Table
Top 50 Insights

View all articles >

Meet the Authors

Francesca Gan

Fran analyses the unprompted online conversations of healthcare professionals to produce actionable insights for clients. Her background in legal research provides a solid foundation in critical thinking and enables a well rounded approach to her data research.

Fran has a keen interest in netball and is a big follower of the New Zealand domestic netball league. She is also a lover of board games and card games, especially ones that involve shouting!

Chawanzi Chintu

As a Marketing assistant,Chawanzi has a passion for creativity and forward-thinking. With a background in media and communications these skills goes hand in hand when it comes to thinking of new and innovative ways to facilitate various marketing processes.

In her free time, Chawanzi balances her time taking care of her cat, pebbles and relaxing with a hydrating face mask.

Suggested next


19.01.2017 | Whitepaper

White Paper: Professional Network: How HCPs are using social media professionally

Written by CEO Daniel Ghinn, originally printed in Innovations in Pharmaceutical Technology

By Daniel Ghinn

HCPs continue to unite in supporting patients and one another online

19.03.2020 | Article

HCPs continue to unite in supporting patients and one another online

HCPs continue to unite in supporting patients and one another online

By Laura McIntyre

View all articles >